Skip to main navigation Skip to search Skip to main content

Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Article number1149
Number of pages18
JournalMolecules
Volume25
Issue number5
DOIs
Publication statusPublished - 4 Mar 2020

Funding

This research was funded by the Austrian Science Fund (FWF), grant number P28853, to C.R.K.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

  • 301904 Cancer research
  • 106002 Biochemistry
  • 106023 Molecular biology

Keywords

  • anticancer
  • tyrosine kinase inhibitors
  • crizotinib
  • prodrugs
  • boronic acid
  • CELL LUNG-CANCER
  • DOCKING
  • Crizotinib
  • Prodrugs
  • Boronic acid
  • Anticancer
  • Tyrosine kinase inhibitors

Fingerprint

Dive into the research topics of 'Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib'. Together they form a unique fingerprint.

Cite this